New hope for tough lymphoma: CAR-T after transplant shows promise
NCT ID NCT06381830
First seen Jun 07, 2026 · Last updated Jun 19, 2026 · Updated 4 times
Summary
This study tested a two-step treatment for people with relapsed or hard-to-treat B-cell non-Hodgkin's lymphoma. First, patients received a stem cell transplant using their own cells, followed by a dose of CAR-T cell therapy. The goal was to see if this combination could improve response rates and keep the cancer from coming back. The study was stopped early after enrolling only 8 participants, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOMA, B-CELL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital of Soochow University
Suzhou, Jiangsu, 215000, China
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.